nodes	percent_of_prediction	percent_of_DWPC	metapath
Furosemide—ALB—chronic obstructive pulmonary disease	0.411	1	CbGaD
Furosemide—SLC22A5—Tiotropium—chronic obstructive pulmonary disease	0.172	0.814	CbGbCtD
Furosemide—ALB—Prednisone—chronic obstructive pulmonary disease	0.0394	0.186	CbGbCtD
Furosemide—CA7—trachea—chronic obstructive pulmonary disease	0.0026	0.0592	CbGeAlD
Furosemide—SLCO2A1—respiratory system—chronic obstructive pulmonary disease	0.00243	0.0553	CbGeAlD
Furosemide—CA12—respiratory system—chronic obstructive pulmonary disease	0.00228	0.0521	CbGeAlD
Furosemide—PGD—respiratory system—chronic obstructive pulmonary disease	0.00216	0.0493	CbGeAlD
Furosemide—CA12—connective tissue—chronic obstructive pulmonary disease	0.00201	0.0458	CbGeAlD
Furosemide—SLCO2A1—bronchus—chronic obstructive pulmonary disease	0.002	0.0455	CbGeAlD
Furosemide—PGD—connective tissue—chronic obstructive pulmonary disease	0.0019	0.0434	CbGeAlD
Furosemide—CA1—respiratory system—chronic obstructive pulmonary disease	0.00181	0.0412	CbGeAlD
Furosemide—SLCO2A1—trachea—chronic obstructive pulmonary disease	0.00179	0.0409	CbGeAlD
Furosemide—PGD—bronchus—chronic obstructive pulmonary disease	0.00178	0.0406	CbGeAlD
Furosemide—PGD—smooth muscle tissue—chronic obstructive pulmonary disease	0.00174	0.0397	CbGeAlD
Furosemide—CA12—trachea—chronic obstructive pulmonary disease	0.00169	0.0385	CbGeAlD
Furosemide—PGD—trachea—chronic obstructive pulmonary disease	0.0016	0.0364	CbGeAlD
Furosemide—CA4—respiratory system—chronic obstructive pulmonary disease	0.00141	0.0322	CbGeAlD
Furosemide—SLCO2A1—lung—chronic obstructive pulmonary disease	0.00129	0.0294	CbGeAlD
Furosemide—CA12—lung—chronic obstructive pulmonary disease	0.00121	0.0276	CbGeAlD
Furosemide—CA2—respiratory system—chronic obstructive pulmonary disease	0.00117	0.0267	CbGeAlD
Furosemide—SLC22A5—respiratory system—chronic obstructive pulmonary disease	0.00115	0.0263	CbGeAlD
Furosemide—PGD—lung—chronic obstructive pulmonary disease	0.00115	0.0262	CbGeAlD
Furosemide—CA5B—lung—chronic obstructive pulmonary disease	0.00109	0.0248	CbGeAlD
Furosemide—CA4—trachea—chronic obstructive pulmonary disease	0.00104	0.0238	CbGeAlD
Furosemide—CA2—connective tissue—chronic obstructive pulmonary disease	0.00103	0.0235	CbGeAlD
Furosemide—CA2—bronchus—chronic obstructive pulmonary disease	0.000965	0.022	CbGeAlD
Furosemide—CA1—lung—chronic obstructive pulmonary disease	0.00096	0.0219	CbGeAlD
Furosemide—SLC22A5—bronchus—chronic obstructive pulmonary disease	0.000949	0.0216	CbGeAlD
Furosemide—CA2—smooth muscle tissue—chronic obstructive pulmonary disease	0.000944	0.0215	CbGeAlD
Furosemide—CA2—trachea—chronic obstructive pulmonary disease	0.000866	0.0197	CbGeAlD
Furosemide—SLC22A5—trachea—chronic obstructive pulmonary disease	0.000852	0.0194	CbGeAlD
Furosemide—CA4—lung—chronic obstructive pulmonary disease	0.000751	0.0171	CbGeAlD
Furosemide—Urinary tract disorder—Salbutamol—chronic obstructive pulmonary disease	0.000638	0.00211	CcSEcCtD
Furosemide—Erythema multiforme—Montelukast—chronic obstructive pulmonary disease	0.000634	0.00209	CcSEcCtD
Furosemide—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.000634	0.00209	CcSEcCtD
Furosemide—Urethral disorder—Salbutamol—chronic obstructive pulmonary disease	0.000634	0.00209	CcSEcCtD
Furosemide—Shock—Aminophylline—chronic obstructive pulmonary disease	0.000629	0.00207	CcSEcCtD
Furosemide—Nervous system disorder—Aminophylline—chronic obstructive pulmonary disease	0.000627	0.00207	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Tiotropium—chronic obstructive pulmonary disease	0.000624	0.00206	CcSEcCtD
Furosemide—CA2—lung—chronic obstructive pulmonary disease	0.000622	0.0142	CbGeAlD
Furosemide—Thrombophlebitis—Prednisolone—chronic obstructive pulmonary disease	0.000619	0.00204	CcSEcCtD
Furosemide—Immune system disorder—Formoterol—chronic obstructive pulmonary disease	0.000618	0.00204	CcSEcCtD
Furosemide—Immune system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000618	0.00204	CcSEcCtD
Furosemide—Diabetes mellitus—Prednisolone—chronic obstructive pulmonary disease	0.000616	0.00203	CcSEcCtD
Furosemide—Dry mouth—Tiotropium—chronic obstructive pulmonary disease	0.000615	0.00203	CcSEcCtD
Furosemide—SLC22A5—lung—chronic obstructive pulmonary disease	0.000612	0.014	CbGeAlD
Furosemide—Arrhythmia—Formoterol—chronic obstructive pulmonary disease	0.000612	0.00202	CcSEcCtD
Furosemide—Arrhythmia—Arformoterol—chronic obstructive pulmonary disease	0.000612	0.00202	CcSEcCtD
Furosemide—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.000609	0.00201	CcSEcCtD
Furosemide—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.000609	0.00201	CcSEcCtD
Furosemide—Immune system disorder—Montelukast—chronic obstructive pulmonary disease	0.000606	0.002	CcSEcCtD
Furosemide—Rash—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.00199	CcSEcCtD
Furosemide—Dermatitis—Roflumilast—chronic obstructive pulmonary disease	0.000604	0.00199	CcSEcCtD
Furosemide—Tinnitus—Salbutamol—chronic obstructive pulmonary disease	0.000603	0.00199	CcSEcCtD
Furosemide—Headache—Roflumilast—chronic obstructive pulmonary disease	0.0006	0.00198	CcSEcCtD
Furosemide—Hypotension—Aminophylline—chronic obstructive pulmonary disease	0.000597	0.00197	CcSEcCtD
Furosemide—Malnutrition—Formoterol—chronic obstructive pulmonary disease	0.000596	0.00197	CcSEcCtD
Furosemide—Malnutrition—Arformoterol—chronic obstructive pulmonary disease	0.000596	0.00197	CcSEcCtD
Furosemide—Shock—Tiotropium—chronic obstructive pulmonary disease	0.000593	0.00196	CcSEcCtD
Furosemide—Nervous system disorder—Tiotropium—chronic obstructive pulmonary disease	0.000591	0.00195	CcSEcCtD
Furosemide—Angiopathy—Salbutamol—chronic obstructive pulmonary disease	0.000587	0.00193	CcSEcCtD
Furosemide—Skin disorder—Tiotropium—chronic obstructive pulmonary disease	0.000585	0.00193	CcSEcCtD
Furosemide—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000584	0.00193	CcSEcCtD
Furosemide—Dysgeusia—Formoterol—chronic obstructive pulmonary disease	0.000584	0.00192	CcSEcCtD
Furosemide—Dysgeusia—Arformoterol—chronic obstructive pulmonary disease	0.000584	0.00192	CcSEcCtD
Furosemide—Arrhythmia—Salbutamol—chronic obstructive pulmonary disease	0.000578	0.0019	CcSEcCtD
Furosemide—Muscle spasms—Formoterol—chronic obstructive pulmonary disease	0.000573	0.00189	CcSEcCtD
Furosemide—Muscle spasms—Arformoterol—chronic obstructive pulmonary disease	0.000573	0.00189	CcSEcCtD
Furosemide—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.000569	0.00188	CcSEcCtD
Furosemide—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.000563	0.00186	CcSEcCtD
Furosemide—Muscle spasms—Montelukast—chronic obstructive pulmonary disease	0.000561	0.00185	CcSEcCtD
Furosemide—Dermatitis bullous—Prednisolone—chronic obstructive pulmonary disease	0.000561	0.00185	CcSEcCtD
Furosemide—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.000556	0.00183	CcSEcCtD
Furosemide—Flatulence—Salbutamol—chronic obstructive pulmonary disease	0.000555	0.00183	CcSEcCtD
Furosemide—Anaphylactoid reaction—Prednisolone—chronic obstructive pulmonary disease	0.000554	0.00183	CcSEcCtD
Furosemide—Dysgeusia—Salbutamol—chronic obstructive pulmonary disease	0.000551	0.00182	CcSEcCtD
Furosemide—Vasculitis—Prednisone—chronic obstructive pulmonary disease	0.00055	0.00181	CcSEcCtD
Furosemide—Agitation—Arformoterol—chronic obstructive pulmonary disease	0.000548	0.00181	CcSEcCtD
Furosemide—Agitation—Formoterol—chronic obstructive pulmonary disease	0.000548	0.00181	CcSEcCtD
Furosemide—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.000541	0.00178	CcSEcCtD
Furosemide—Muscle spasms—Salbutamol—chronic obstructive pulmonary disease	0.000541	0.00178	CcSEcCtD
Furosemide—Agitation—Montelukast—chronic obstructive pulmonary disease	0.000537	0.00177	CcSEcCtD
Furosemide—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.000523	0.00172	CcSEcCtD
Furosemide—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00052	0.00172	CcSEcCtD
Furosemide—Agitation—Salbutamol—chronic obstructive pulmonary disease	0.000517	0.00171	CcSEcCtD
Furosemide—Constipation—Tiotropium—chronic obstructive pulmonary disease	0.000515	0.0017	CcSEcCtD
Furosemide—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.000508	0.00167	CcSEcCtD
Furosemide—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.000506	0.00167	CcSEcCtD
Furosemide—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00167	CcSEcCtD
Furosemide—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.000505	0.00167	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.000504	0.00166	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.000504	0.00166	CcSEcCtD
Furosemide—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.000496	0.00164	CcSEcCtD
Furosemide—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.000496	0.00164	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.000494	0.00163	CcSEcCtD
Furosemide—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.000493	0.00163	CcSEcCtD
Furosemide—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.000486	0.0016	CcSEcCtD
Furosemide—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.000486	0.0016	CcSEcCtD
Furosemide—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000479	0.00158	CcSEcCtD
Furosemide—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000477	0.00157	CcSEcCtD
Furosemide—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000477	0.00157	CcSEcCtD
Furosemide—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000476	0.00157	CcSEcCtD
Furosemide—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000476	0.00157	CcSEcCtD
Furosemide—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000473	0.00156	CcSEcCtD
Furosemide—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000473	0.00156	CcSEcCtD
Furosemide—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000473	0.00156	CcSEcCtD
Furosemide—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000471	0.00155	CcSEcCtD
Furosemide—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000469	0.00155	CcSEcCtD
Furosemide—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00154	CcSEcCtD
Furosemide—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000467	0.00154	CcSEcCtD
Furosemide—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000466	0.00154	CcSEcCtD
Furosemide—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000463	0.00153	CcSEcCtD
Furosemide—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000459	0.00151	CcSEcCtD
Furosemide—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000455	0.0015	CcSEcCtD
Furosemide—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000455	0.0015	CcSEcCtD
Furosemide—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.000454	0.0015	CcSEcCtD
Furosemide—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000452	0.00149	CcSEcCtD
Furosemide—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.00149	CcSEcCtD
Furosemide—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00045	0.00149	CcSEcCtD
Furosemide—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00045	0.00148	CcSEcCtD
Furosemide—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000448	0.00148	CcSEcCtD
Furosemide—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.000446	0.00147	CcSEcCtD
Furosemide—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000444	0.00146	CcSEcCtD
Furosemide—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000444	0.00146	CcSEcCtD
Furosemide—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.00144	CcSEcCtD
Furosemide—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000437	0.00144	CcSEcCtD
Furosemide—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000435	0.00144	CcSEcCtD
Furosemide—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000432	0.00143	CcSEcCtD
Furosemide—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000432	0.00143	CcSEcCtD
Furosemide—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000429	0.00142	CcSEcCtD
Furosemide—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000428	0.00141	CcSEcCtD
Furosemide—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000426	0.00141	CcSEcCtD
Furosemide—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000424	0.0014	CcSEcCtD
Furosemide—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000423	0.00139	CcSEcCtD
Furosemide—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00042	0.00139	CcSEcCtD
Furosemide—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00042	0.00139	CcSEcCtD
Furosemide—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.00138	CcSEcCtD
Furosemide—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000419	0.00138	CcSEcCtD
Furosemide—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00137	CcSEcCtD
Furosemide—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00137	CcSEcCtD
Furosemide—Pain—Formoterol—chronic obstructive pulmonary disease	0.000416	0.00137	CcSEcCtD
Furosemide—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000416	0.00137	CcSEcCtD
Furosemide—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000412	0.00136	CcSEcCtD
Furosemide—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00136	CcSEcCtD
Furosemide—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000411	0.00135	CcSEcCtD
Furosemide—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000408	0.00135	CcSEcCtD
Furosemide—Pain—Montelukast—chronic obstructive pulmonary disease	0.000407	0.00134	CcSEcCtD
Furosemide—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000406	0.00134	CcSEcCtD
Furosemide—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000404	0.00133	CcSEcCtD
Furosemide—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00133	CcSEcCtD
Furosemide—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000403	0.00133	CcSEcCtD
Furosemide—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000401	0.00132	CcSEcCtD
Furosemide—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000401	0.00132	CcSEcCtD
Furosemide—Headache—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.00132	CcSEcCtD
Furosemide—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.00132	CcSEcCtD
Furosemide—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000399	0.00131	CcSEcCtD
Furosemide—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000398	0.00131	CcSEcCtD
Furosemide—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000398	0.00131	CcSEcCtD
Furosemide—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000397	0.00131	CcSEcCtD
Furosemide—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000397	0.00131	CcSEcCtD
Furosemide—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00131	CcSEcCtD
Furosemide—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.0013	CcSEcCtD
Furosemide—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000393	0.0013	CcSEcCtD
Furosemide—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00039	0.00128	CcSEcCtD
Furosemide—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000386	0.00127	CcSEcCtD
Furosemide—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000386	0.00127	CcSEcCtD
Furosemide—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00127	CcSEcCtD
Furosemide—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00127	CcSEcCtD
Furosemide—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000385	0.00127	CcSEcCtD
Furosemide—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000385	0.00127	CcSEcCtD
Furosemide—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000383	0.00126	CcSEcCtD
Furosemide—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00125	CcSEcCtD
Furosemide—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00038	0.00125	CcSEcCtD
Furosemide—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00038	0.00125	CcSEcCtD
Furosemide—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000379	0.00125	CcSEcCtD
Furosemide—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000379	0.00125	CcSEcCtD
Furosemide—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000378	0.00125	CcSEcCtD
Furosemide—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00124	CcSEcCtD
Furosemide—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000377	0.00124	CcSEcCtD
Furosemide—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000376	0.00124	CcSEcCtD
Furosemide—Irritability—Prednisone—chronic obstructive pulmonary disease	0.000372	0.00123	CcSEcCtD
Furosemide—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000365	0.0012	CcSEcCtD
Furosemide—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.0012	CcSEcCtD
Furosemide—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000363	0.0012	CcSEcCtD
Furosemide—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000358	0.00118	CcSEcCtD
Furosemide—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000358	0.00118	CcSEcCtD
Furosemide—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000358	0.00118	CcSEcCtD
Furosemide—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000357	0.00118	CcSEcCtD
Furosemide—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000354	0.00117	CcSEcCtD
Furosemide—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.000351	0.00116	CcSEcCtD
Furosemide—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000349	0.00115	CcSEcCtD
Furosemide—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000349	0.00115	CcSEcCtD
Furosemide—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000344	0.00114	CcSEcCtD
Furosemide—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000344	0.00114	CcSEcCtD
Furosemide—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000344	0.00113	CcSEcCtD
Furosemide—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000342	0.00113	CcSEcCtD
Furosemide—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000339	0.00112	CcSEcCtD
Furosemide—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000338	0.00112	CcSEcCtD
Furosemide—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000337	0.00111	CcSEcCtD
Furosemide—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000333	0.0011	CcSEcCtD
Furosemide—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000333	0.0011	CcSEcCtD
Furosemide—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000331	0.00109	CcSEcCtD
Furosemide—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00033	0.00109	CcSEcCtD
Furosemide—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00033	0.00109	CcSEcCtD
Furosemide—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000326	0.00108	CcSEcCtD
Furosemide—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000325	0.00107	CcSEcCtD
Furosemide—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.000323	0.00106	CcSEcCtD
Furosemide—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000322	0.00106	CcSEcCtD
Furosemide—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000322	0.00106	CcSEcCtD
Furosemide—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000315	0.00104	CcSEcCtD
Furosemide—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000314	0.00104	CcSEcCtD
Furosemide—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000309	0.00102	CcSEcCtD
Furosemide—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000309	0.00102	CcSEcCtD
Furosemide—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000307	0.00101	CcSEcCtD
Furosemide—Rash—Formoterol—chronic obstructive pulmonary disease	0.000307	0.00101	CcSEcCtD
Furosemide—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000306	0.00101	CcSEcCtD
Furosemide—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000306	0.00101	CcSEcCtD
Furosemide—Headache—Formoterol—chronic obstructive pulmonary disease	0.000305	0.00101	CcSEcCtD
Furosemide—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000305	0.00101	CcSEcCtD
Furosemide—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000304	0.001	CcSEcCtD
Furosemide—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000304	0.001	CcSEcCtD
Furosemide—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000304	0.001	CcSEcCtD
Furosemide—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000303	0.000999	CcSEcCtD
Furosemide—Rash—Montelukast—chronic obstructive pulmonary disease	0.0003	0.000991	CcSEcCtD
Furosemide—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.0003	0.00099	CcSEcCtD
Furosemide—Headache—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000984	CcSEcCtD
Furosemide—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000292	0.000963	CcSEcCtD
Furosemide—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.00029	0.000956	CcSEcCtD
Furosemide—Rash—Salbutamol—chronic obstructive pulmonary disease	0.00029	0.000955	CcSEcCtD
Furosemide—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000289	0.000954	CcSEcCtD
Furosemide—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000289	0.000953	CcSEcCtD
Furosemide—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000289	0.000953	CcSEcCtD
Furosemide—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000288	0.000949	CcSEcCtD
Furosemide—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000283	0.000933	CcSEcCtD
Furosemide—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000273	0.0009	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000263	0.000869	CcSEcCtD
Furosemide—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000259	0.000855	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000255	0.00084	CcSEcCtD
Furosemide—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000252	0.00083	CcSEcCtD
Furosemide—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000244	0.000806	CcSEcCtD
Furosemide—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000243	0.000803	CcSEcCtD
Furosemide—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000241	0.000794	CcSEcCtD
Furosemide—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.00078	CcSEcCtD
Furosemide—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000774	CcSEcCtD
Furosemide—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000235	0.000774	CcSEcCtD
Furosemide—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000225	0.000743	CcSEcCtD
Furosemide—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000221	0.000729	CcSEcCtD
Furosemide—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000217	0.000716	CcSEcCtD
Furosemide—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000715	CcSEcCtD
Furosemide—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000216	0.000711	CcSEcCtD
Furosemide—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000211	0.000695	CcSEcCtD
Furosemide—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000209	0.00069	CcSEcCtD
Furosemide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000654	CcSEcCtD
Furosemide—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000194	0.00064	CcSEcCtD
Furosemide—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000191	0.000631	CcSEcCtD
Furosemide—Shock—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000621	CcSEcCtD
Furosemide—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000188	0.000619	CcSEcCtD
Furosemide—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000186	0.000613	CcSEcCtD
Furosemide—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000185	0.00061	CcSEcCtD
Furosemide—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000602	CcSEcCtD
Furosemide—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000575	CcSEcCtD
Furosemide—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000172	0.000567	CcSEcCtD
Furosemide—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000549	CcSEcCtD
Furosemide—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000548	CcSEcCtD
Furosemide—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000166	0.000547	CcSEcCtD
Furosemide—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000544	CcSEcCtD
Furosemide—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000544	CcSEcCtD
Furosemide—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000164	0.00054	CcSEcCtD
Furosemide—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000158	0.00052	CcSEcCtD
Furosemide—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000157	0.000516	CcSEcCtD
Furosemide—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000156	0.000516	CcSEcCtD
Furosemide—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000152	0.000502	CcSEcCtD
Furosemide—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000499	CcSEcCtD
Furosemide—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000151	0.000499	CcSEcCtD
Furosemide—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000141	0.000465	CcSEcCtD
Furosemide—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000137	0.000453	CcSEcCtD
Furosemide—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000135	0.000447	CcSEcCtD
Furosemide—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000131	0.000432	CcSEcCtD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINA1—chronic obstructive pulmonary disease	0.000131	0.00431	CbGpPWpGaD
Furosemide—CA5A—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000127	0.0042	CbGpPWpGaD
Furosemide—CA6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000127	0.0042	CbGpPWpGaD
Furosemide—CA14—Metabolism—GC—chronic obstructive pulmonary disease	0.000127	0.00419	CbGpPWpGaD
Furosemide—CA2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000127	0.00419	CbGpPWpGaD
Furosemide—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000417	CcSEcCtD
Furosemide—CA6—Metabolism—GC—chronic obstructive pulmonary disease	0.000124	0.00408	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GC—chronic obstructive pulmonary disease	0.000124	0.00408	CbGpPWpGaD
Furosemide—SLCO2A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000123	0.00406	CbGpPWpGaD
Furosemide—PGD—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000123	0.00405	CbGpPWpGaD
Furosemide—CA1—Metabolism—APIP—chronic obstructive pulmonary disease	0.000122	0.00402	CbGpPWpGaD
Furosemide—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000122	0.000401	CcSEcCtD
Furosemide—Rash—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000398	CcSEcCtD
Furosemide—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000121	0.000398	CcSEcCtD
Furosemide—Headache—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000396	CcSEcCtD
Furosemide—ALB—Selenium Micronutrient Network—MPO—chronic obstructive pulmonary disease	0.00012	0.00395	CbGpPWpGaD
Furosemide—PGD—Metabolism—GC—chronic obstructive pulmonary disease	0.000119	0.00394	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB2—chronic obstructive pulmonary disease	0.000119	0.00392	CbGpPWpGaD
Furosemide—CA7—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000119	0.00392	CbGpPWpGaD
Furosemide—CA5B—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000119	0.00392	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000118	0.0039	CbGpPWpGaD
Furosemide—CA7—Metabolism—GC—chronic obstructive pulmonary disease	0.000116	0.00381	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GC—chronic obstructive pulmonary disease	0.000116	0.00381	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000115	0.0038	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000115	0.0038	CbGpPWpGaD
Furosemide—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000114	0.000375	CcSEcCtD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB2—chronic obstructive pulmonary disease	0.000113	0.00373	CbGpPWpGaD
Furosemide—PGD—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000113	0.00373	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000111	0.00366	CbGpPWpGaD
Furosemide—CA12—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00011	0.00363	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—GSTP1—chronic obstructive pulmonary disease	0.000108	0.00358	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000107	0.00354	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000107	0.00354	CbGpPWpGaD
Furosemide—CA9—Metabolism—APIP—chronic obstructive pulmonary disease	0.000107	0.00353	CbGpPWpGaD
Furosemide—CA12—Metabolism—GC—chronic obstructive pulmonary disease	0.000107	0.00353	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—RAPGEF3—chronic obstructive pulmonary disease	0.000106	0.00349	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000104	0.00343	CbGpPWpGaD
Furosemide—SLC12A1—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000103	0.00339	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000101	0.00334	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	9.98e-05	0.00329	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	9.95e-05	0.00328	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—CRP—chronic obstructive pulmonary disease	9.73e-05	0.00321	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	9.3e-05	0.00307	CbGpPWpGaD
Furosemide—CA4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.78e-05	0.0029	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	8.74e-05	0.00288	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	8.69e-05	0.00287	CbGpPWpGaD
Furosemide—CA4—Metabolism—GC—chronic obstructive pulmonary disease	8.54e-05	0.00282	CbGpPWpGaD
Furosemide—CA2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.41e-05	0.00278	CbGpPWpGaD
Furosemide—CA2—Metabolism—GC—chronic obstructive pulmonary disease	8.18e-05	0.0027	CbGpPWpGaD
Furosemide—CA1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.07e-05	0.00266	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.94e-05	0.00262	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—CRP—chronic obstructive pulmonary disease	7.92e-05	0.00261	CbGpPWpGaD
Furosemide—CA1—Metabolism—GC—chronic obstructive pulmonary disease	7.85e-05	0.00259	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	7.79e-05	0.00257	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.61e-05	0.00251	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—SERPINE1—chronic obstructive pulmonary disease	7.47e-05	0.00247	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.29e-05	0.00241	CbGpPWpGaD
Furosemide—CA9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	7.09e-05	0.00234	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.94e-05	0.00229	CbGpPWpGaD
Furosemide—CA9—Metabolism—GC—chronic obstructive pulmonary disease	6.9e-05	0.00228	CbGpPWpGaD
Furosemide—CA14—Metabolism—GCLC—chronic obstructive pulmonary disease	6.86e-05	0.00226	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.76e-05	0.00223	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.76e-05	0.00223	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GCLC—chronic obstructive pulmonary disease	6.68e-05	0.00221	CbGpPWpGaD
Furosemide—CA6—Metabolism—GCLC—chronic obstructive pulmonary disease	6.68e-05	0.00221	CbGpPWpGaD
Furosemide—PGD—Disease—HDAC2—chronic obstructive pulmonary disease	6.55e-05	0.00216	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.52e-05	0.00215	CbGpPWpGaD
Furosemide—PGD—Metabolism—GCLC—chronic obstructive pulmonary disease	6.45e-05	0.00213	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	6.41e-05	0.00212	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.31e-05	0.00208	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.31e-05	0.00208	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—CRP—chronic obstructive pulmonary disease	6.29e-05	0.00208	CbGpPWpGaD
Furosemide—CA14—Metabolism—CTGF—chronic obstructive pulmonary disease	6.26e-05	0.00206	CbGpPWpGaD
Furosemide—SLCO2A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.25e-05	0.00206	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE2—chronic obstructive pulmonary disease	6.24e-05	0.00206	CbGpPWpGaD
Furosemide—CA7—Metabolism—GCLC—chronic obstructive pulmonary disease	6.24e-05	0.00206	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GCLC—chronic obstructive pulmonary disease	6.24e-05	0.00206	CbGpPWpGaD
Furosemide—SLC22A11—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	6.13e-05	0.00202	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CTGF—chronic obstructive pulmonary disease	6.1e-05	0.00201	CbGpPWpGaD
Furosemide—CA6—Metabolism—CTGF—chronic obstructive pulmonary disease	6.1e-05	0.00201	CbGpPWpGaD
Furosemide—PGD—Disease—KL—chronic obstructive pulmonary disease	6.09e-05	0.00201	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—SERPINE1—chronic obstructive pulmonary disease	6.08e-05	0.00201	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINA1—chronic obstructive pulmonary disease	6.08e-05	0.00201	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL1B—chronic obstructive pulmonary disease	6.07e-05	0.002	CbGpPWpGaD
Furosemide—PGD—Metabolism—CTGF—chronic obstructive pulmonary disease	5.88e-05	0.00194	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTT1—chronic obstructive pulmonary disease	5.85e-05	0.00193	CbGpPWpGaD
Furosemide—CA12—Metabolism—GCLC—chronic obstructive pulmonary disease	5.78e-05	0.00191	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.77e-05	0.0019	CbGpPWpGaD
Furosemide—CA7—Metabolism—CTGF—chronic obstructive pulmonary disease	5.69e-05	0.00188	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CTGF—chronic obstructive pulmonary disease	5.69e-05	0.00188	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.62e-05	0.00185	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.62e-05	0.00185	CbGpPWpGaD
Furosemide—ALB—Hemostasis—RAPGEF3—chronic obstructive pulmonary disease	5.45e-05	0.0018	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	5.45e-05	0.0018	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.42e-05	0.00179	CbGpPWpGaD
Furosemide—CA12—Metabolism—CTGF—chronic obstructive pulmonary disease	5.27e-05	0.00174	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB2—chronic obstructive pulmonary disease	5.27e-05	0.00174	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00173	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.25e-05	0.00173	CbGpPWpGaD
Furosemide—SLC12A1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.22e-05	0.00172	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—SERPINE1—chronic obstructive pulmonary disease	5.21e-05	0.00172	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	5.18e-05	0.00171	CbGpPWpGaD
Furosemide—SLC22A5—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	5.17e-05	0.0017	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—chronic obstructive pulmonary disease	4.97e-05	0.00164	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL1B—chronic obstructive pulmonary disease	4.94e-05	0.00163	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP1A2—chronic obstructive pulmonary disease	4.86e-05	0.0016	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—SERPINE1—chronic obstructive pulmonary disease	4.83e-05	0.00159	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	4.83e-05	0.00159	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.81e-05	0.00159	CbGpPWpGaD
Furosemide—CA14—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.74e-05	0.00156	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.69e-05	0.00155	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.69e-05	0.00155	CbGpPWpGaD
Furosemide—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	4.67e-05	0.00154	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.66e-05	0.00154	CbGpPWpGaD
Furosemide—CA5A—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.62e-05	0.00152	CbGpPWpGaD
Furosemide—CA6—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.62e-05	0.00152	CbGpPWpGaD
Furosemide—CA4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.61e-05	0.00152	CbGpPWpGaD
Furosemide—PGD—Disease—ERBB3—chronic obstructive pulmonary disease	4.56e-05	0.00151	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.52e-05	0.00149	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.47e-05	0.00148	CbGpPWpGaD
Furosemide—PGD—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.46e-05	0.00147	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	4.42e-05	0.00146	CbGpPWpGaD
Furosemide—CA14—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.42e-05	0.00146	CbGpPWpGaD
Furosemide—CA2—Metabolism—GCLC—chronic obstructive pulmonary disease	4.42e-05	0.00146	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—TNF—chronic obstructive pulmonary disease	4.41e-05	0.00145	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.00144	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.38e-05	0.00144	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.37e-05	0.00144	CbGpPWpGaD
Furosemide—CA7—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.32e-05	0.00142	CbGpPWpGaD
Furosemide—CA5B—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.32e-05	0.00142	CbGpPWpGaD
Furosemide—CA5A—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.31e-05	0.00142	CbGpPWpGaD
Furosemide—CA6—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.31e-05	0.00142	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.29e-05	0.00141	CbGpPWpGaD
Furosemide—CA1—Metabolism—GCLC—chronic obstructive pulmonary disease	4.24e-05	0.0014	CbGpPWpGaD
Furosemide—CA4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.21e-05	0.00139	CbGpPWpGaD
Furosemide—CA14—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.19e-05	0.00138	CbGpPWpGaD
Furosemide—PGD—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.16e-05	0.00137	CbGpPWpGaD
Furosemide—CA5A—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.00135	CbGpPWpGaD
Furosemide—CA6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.08e-05	0.00135	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.05e-05	0.00134	CbGpPWpGaD
Furosemide—CA2—Metabolism—CTGF—chronic obstructive pulmonary disease	4.03e-05	0.00133	CbGpPWpGaD
Furosemide—CA7—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.02e-05	0.00133	CbGpPWpGaD
Furosemide—CA5B—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.02e-05	0.00133	CbGpPWpGaD
Furosemide—CA12—Metabolism—HMOX1—chronic obstructive pulmonary disease	4e-05	0.00132	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.95e-05	0.0013	CbGpPWpGaD
Furosemide—PGD—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.94e-05	0.0013	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL1B—chronic obstructive pulmonary disease	3.92e-05	0.00129	CbGpPWpGaD
Furosemide—SLC22A6—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	3.9e-05	0.00129	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.88e-05	0.00128	CbGpPWpGaD
Furosemide—CA1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.87e-05	0.00128	CbGpPWpGaD
Furosemide—CA7—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-05	0.00126	CbGpPWpGaD
Furosemide—CA5B—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.81e-05	0.00126	CbGpPWpGaD
Furosemide—PGD—Disease—NOS2—chronic obstructive pulmonary disease	3.8e-05	0.00126	CbGpPWpGaD
Furosemide—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	3.79e-05	0.00125	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.77e-05	0.00124	CbGpPWpGaD
Furosemide—CA12—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.72e-05	0.00123	CbGpPWpGaD
Furosemide—CA9—Metabolism—GCLC—chronic obstructive pulmonary disease	3.72e-05	0.00123	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.72e-05	0.00123	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—VEGFA—chronic obstructive pulmonary disease	3.59e-05	0.00118	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TNF—chronic obstructive pulmonary disease	3.58e-05	0.00118	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.56e-05	0.00118	CbGpPWpGaD
Furosemide—ALB—Vitamin B12 Metabolism—IL6—chronic obstructive pulmonary disease	3.56e-05	0.00117	CbGpPWpGaD
Furosemide—CA12—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.53e-05	0.00117	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—chronic obstructive pulmonary disease	3.42e-05	0.00113	CbGpPWpGaD
Furosemide—CA9—Metabolism—CTGF—chronic obstructive pulmonary disease	3.4e-05	0.00112	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	3.34e-05	0.0011	CbGpPWpGaD
Furosemide—ALB—Metabolism—APIP—chronic obstructive pulmonary disease	3.34e-05	0.0011	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.3e-05	0.00109	CbGpPWpGaD
Furosemide—ALB—Platelet degranulation—TGFB1—chronic obstructive pulmonary disease	3.29e-05	0.00109	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.23e-05	0.00107	CbGpPWpGaD
Furosemide—PGD—Disease—SERPINE1—chronic obstructive pulmonary disease	3.2e-05	0.00106	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	3.2e-05	0.00105	CbGpPWpGaD
Furosemide—CA4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.19e-05	0.00105	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—TP53—chronic obstructive pulmonary disease	3.16e-05	0.00104	CbGpPWpGaD
Furosemide—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—chronic obstructive pulmonary disease	3.14e-05	0.00103	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINA1—chronic obstructive pulmonary disease	3.13e-05	0.00103	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.13e-05	0.00103	CbGpPWpGaD
Furosemide—SLC22A11—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	3.11e-05	0.00103	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.1e-05	0.00102	CbGpPWpGaD
Furosemide—CA9—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	3.06e-05	0.00101	CbGpPWpGaD
Furosemide—PGD—Disease—NOS3—chronic obstructive pulmonary disease	3.06e-05	0.00101	CbGpPWpGaD
Furosemide—CA2—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.06e-05	0.00101	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.97e-05	0.00098	CbGpPWpGaD
Furosemide—CA4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.97e-05	0.00098	CbGpPWpGaD
Furosemide—CA1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.93e-05	0.000967	CbGpPWpGaD
Furosemide—ALB—Folate Metabolism—IL6—chronic obstructive pulmonary disease	2.89e-05	0.000954	CbGpPWpGaD
Furosemide—CA14—Metabolism—ALB—chronic obstructive pulmonary disease	2.85e-05	0.00094	CbGpPWpGaD
Furosemide—CA2—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.85e-05	0.00094	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—TNF—chronic obstructive pulmonary disease	2.85e-05	0.00094	CbGpPWpGaD
Furosemide—CA4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.82e-05	0.000929	CbGpPWpGaD
Furosemide—CA5A—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000916	CbGpPWpGaD
Furosemide—CA6—Metabolism—ALB—chronic obstructive pulmonary disease	2.78e-05	0.000916	CbGpPWpGaD
Furosemide—CA1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.73e-05	0.000901	CbGpPWpGaD
Furosemide—CA14—Metabolism—NOS3—chronic obstructive pulmonary disease	2.72e-05	0.000899	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB2—chronic obstructive pulmonary disease	2.72e-05	0.000896	CbGpPWpGaD
Furosemide—CA2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.7e-05	0.000891	CbGpPWpGaD
Furosemide—PGD—Metabolism—ALB—chronic obstructive pulmonary disease	2.68e-05	0.000883	CbGpPWpGaD
Furosemide—CA5A—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-05	0.000876	CbGpPWpGaD
Furosemide—CA6—Metabolism—NOS3—chronic obstructive pulmonary disease	2.65e-05	0.000876	CbGpPWpGaD
Furosemide—SLC22A5—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.62e-05	0.000866	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.61e-05	0.000862	CbGpPWpGaD
Furosemide—CA7—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-05	0.000855	CbGpPWpGaD
Furosemide—CA5B—Metabolism—ALB—chronic obstructive pulmonary disease	2.59e-05	0.000855	CbGpPWpGaD
Furosemide—CA1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.59e-05	0.000854	CbGpPWpGaD
Furosemide—CA9—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.58e-05	0.00085	CbGpPWpGaD
Furosemide—PGD—Metabolism—NOS3—chronic obstructive pulmonary disease	2.56e-05	0.000845	CbGpPWpGaD
Furosemide—CA5B—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-05	0.000818	CbGpPWpGaD
Furosemide—CA7—Metabolism—NOS3—chronic obstructive pulmonary disease	2.48e-05	0.000818	CbGpPWpGaD
Furosemide—ALB—Hemostasis—HDAC2—chronic obstructive pulmonary disease	2.44e-05	0.000804	CbGpPWpGaD
Furosemide—CA12—Metabolism—ALB—chronic obstructive pulmonary disease	2.4e-05	0.000792	CbGpPWpGaD
Furosemide—CA9—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.4e-05	0.000792	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	2.38e-05	0.000785	CbGpPWpGaD
Furosemide—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.37e-05	0.000783	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—SERPINE1—chronic obstructive pulmonary disease	2.31e-05	0.000763	CbGpPWpGaD
Furosemide—ALB—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	2.3e-05	0.000758	CbGpPWpGaD
Furosemide—CA12—Metabolism—NOS3—chronic obstructive pulmonary disease	2.3e-05	0.000758	CbGpPWpGaD
Furosemide—CA9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.28e-05	0.000751	CbGpPWpGaD
Furosemide—ALB—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	2.21e-05	0.00073	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAUR—chronic obstructive pulmonary disease	2.2e-05	0.000725	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	2.19e-05	0.000724	CbGpPWpGaD
Furosemide—ALB—Metabolism—GC—chronic obstructive pulmonary disease	2.15e-05	0.00071	CbGpPWpGaD
Furosemide—PGD—Disease—TGFB1—chronic obstructive pulmonary disease	2.02e-05	0.000667	CbGpPWpGaD
Furosemide—ALB—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	2e-05	0.00066	CbGpPWpGaD
Furosemide—PGD—Disease—EGFR—chronic obstructive pulmonary disease	1.98e-05	0.000654	CbGpPWpGaD
Furosemide—SLC22A6—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.98e-05	0.000654	CbGpPWpGaD
Furosemide—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.92e-05	0.000633	CbGpPWpGaD
Furosemide—CA4—Metabolism—ALB—chronic obstructive pulmonary disease	1.91e-05	0.000632	CbGpPWpGaD
Furosemide—CA2—Metabolism—ALB—chronic obstructive pulmonary disease	1.84e-05	0.000605	CbGpPWpGaD
Furosemide—CA4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.83e-05	0.000604	CbGpPWpGaD
Furosemide—CA1—Metabolism—ALB—chronic obstructive pulmonary disease	1.76e-05	0.00058	CbGpPWpGaD
Furosemide—CA2—Metabolism—NOS3—chronic obstructive pulmonary disease	1.76e-05	0.000579	CbGpPWpGaD
Furosemide—ALB—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	1.72e-05	0.000566	CbGpPWpGaD
Furosemide—CA1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.68e-05	0.000555	CbGpPWpGaD
Furosemide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	1.59e-05	0.000526	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—VEGFA—chronic obstructive pulmonary disease	1.59e-05	0.000525	CbGpPWpGaD
Furosemide—ALB—Hemostasis—MMP1—chronic obstructive pulmonary disease	1.57e-05	0.000518	CbGpPWpGaD
Furosemide—CA9—Metabolism—ALB—chronic obstructive pulmonary disease	1.55e-05	0.00051	CbGpPWpGaD
Furosemide—ALB—Hemostasis—PLAU—chronic obstructive pulmonary disease	1.54e-05	0.000508	CbGpPWpGaD
Furosemide—PGD—Disease—IL6—chronic obstructive pulmonary disease	1.52e-05	0.000503	CbGpPWpGaD
Furosemide—CA9—Metabolism—NOS3—chronic obstructive pulmonary disease	1.48e-05	0.000488	CbGpPWpGaD
Furosemide—ALB—Platelet activation, signaling and aggregation—TGFB1—chronic obstructive pulmonary disease	1.46e-05	0.000482	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS2—chronic obstructive pulmonary disease	1.42e-05	0.000467	CbGpPWpGaD
Furosemide—ALB—Hemostasis—SERPINE1—chronic obstructive pulmonary disease	1.19e-05	0.000393	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTT1—chronic obstructive pulmonary disease	1.18e-05	0.000388	CbGpPWpGaD
Furosemide—ALB—Metabolism—GCLC—chronic obstructive pulmonary disease	1.16e-05	0.000383	CbGpPWpGaD
Furosemide—ALB—Hemostasis—NOS3—chronic obstructive pulmonary disease	1.14e-05	0.000375	CbGpPWpGaD
Furosemide—ALB—Metabolism—CTGF—chronic obstructive pulmonary disease	1.06e-05	0.00035	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1A2—chronic obstructive pulmonary disease	9.77e-06	0.000322	CbGpPWpGaD
Furosemide—ALB—Hemostasis—VEGFA—chronic obstructive pulmonary disease	8.2e-06	0.00027	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTP1—chronic obstructive pulmonary disease	8.15e-06	0.000269	CbGpPWpGaD
Furosemide—ALB—Metabolism—HMOX1—chronic obstructive pulmonary disease	8.03e-06	0.000265	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TGFB1—chronic obstructive pulmonary disease	7.53e-06	0.000248	CbGpPWpGaD
Furosemide—ALB—Metabolism—GSTM1—chronic obstructive pulmonary disease	7.49e-06	0.000247	CbGpPWpGaD
Furosemide—ALB—Metabolism—CYP1A1—chronic obstructive pulmonary disease	7.1e-06	0.000234	CbGpPWpGaD
Furosemide—ALB—Hemostasis—TP53—chronic obstructive pulmonary disease	6.19e-06	0.000204	CbGpPWpGaD
Furosemide—ALB—Metabolism—NOS3—chronic obstructive pulmonary disease	4.61e-06	0.000152	CbGpPWpGaD
